Sept 8 (Reuters) – Eli Lilly’s (LLY.N) diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly… [+1477 chars]Read More
Lillys diabetes drug gains backing of UK watchdog Bloomberg News Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FAQTJ67KUNKL3H6NZ4DIJMOMOI.jpg)
